Promotion
mRNA 15% OFF + Buy NTPs, get DNase I
EPO mRNA (N1-Me-Pseudo U)
| Catalog No. | ON-242 |
| Purity | N/A |
| Source | N/A |
EPO mRNA (N1-Me-Pseudo U)
EPO mRNA (N1-Me-Pseudo U) - M (Molecular Biology) / 1mg / centrifuge tube is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Details
Details
EPO mRNA is a messenger RNA molecule that encodes erythropoietin (EPO).Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, while reducing immunogenicity. It is widely used in mRNA drug research and development and the evaluation of delivery systems.
Concentration: 1.0 mg/mL
Buffer: 1 mM Sodium Citrate pH 6.4
Modifications: N1-Methyl-Pseudo-U
Endotoxin: < 1 EU/mg
Bioanalyzer of Final Product: Passes Capillary Electrophoresis
Specifications
Specifications
-
Catalog No.ON-242
-
SourceN/A
-
PurityN/A
Documentation
Documentation
EPO mRNA is a messenger RNA molecule that encodes erythropoietin (EPO).Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, while reducing immunogenicity. It is widely used in mRNA drug research and development and the evaluation of delivery systems.
Concentration: 1.0 mg/mL
Buffer: 1 mM Sodium Citrate pH 6.4
Modifications: N1-Methyl-Pseudo-U
Endotoxin: < 1 EU/mg
Bioanalyzer of Final Product: Passes Capillary Electrophoresis
-
Catalog No.ON-242
-
SourceN/A
-
PurityN/A
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With nearly 30 years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
